Zantac is the trade name for Ranitidine, a popular medication that reduces the body’s production of stomach acid. At one point Zantac was the top selling drug in the world – now the U.S. Food and Drug Administration (FDA) is investigating whether the popular over-the-counter heartburn medication causes carcinogens to form in its users. The
Read More >Zantac Cancer Risk: Explosion of Potential Lawsuits Predicted
Reply